Login / Signup
RE: One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study.
Michael Pazianas
Published in:
Calcified tissue international (2022)
Keyphrases
</>
end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
prognostic factors
body composition
patient reported outcomes